Randomised trial examining clinical and cost effectiveness of three antithrombotic regimens following endovascular lower limb revascularisation for chronic limb threatening ischaemia: CLARITY (CLopidogrel, Aspirin and RIvaroxaban after revascularIsation with angioplasTY)
National Institute for Health and Care Research
· United Kingdom · £25.76M GBP
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.